| 000 | 01622aam a22004578i 4500 | ||
|---|---|---|---|
| 999 |
_c12860 _d12860 |
||
| 001 | 9925841653602122 | ||
| 005 | 20210304155507.0 | ||
| 008 | 920714t19931993nyua b 001 0 eng | ||
| 010 | _a 92023366 | ||
| 020 | _a082478801X | ||
| 035 | _a(OCoLC)26300563 | ||
| 035 | _a(WU)2584165-uwmadisondb | ||
| 035 | _a(EXLNZ-01UWI_NETWORK)999699270502121 | ||
| 040 |
_aDLC _beng _cDLC _dEG-NcFUE _erda |
||
| 043 | _an-us--- | ||
| 049 | _aGZZW | ||
| 050 | 0 | 0 |
_aRS189 _b.N475 1993 |
| 082 | 0 | 4 |
_222 _a363.19460973 _bN |
| 096 | _aQV 771 N5318 1992 | ||
| 245 | 0 | 0 |
_aNew drug approval process / _cedited by Richard A. Guarino. |
| 250 | _aSecond edition, revised and expanded. | ||
| 264 | 1 |
_aNew York : _bM. Dekker, _c[1993] |
|
| 264 | 4 | _c©1993 | |
| 300 |
_axxi, 469 pages ; _c24 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 490 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 56 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 610 | 1 | 0 |
_aUnited States. _bFood and Drug Administration. |
| 650 | 0 |
_aDrugs _xTesting _xStandards. |
|
| 650 | 0 |
_aDrugs _xTesting _xGovernment policy _zUnited States. |
|
| 650 | 0 |
_aNew products _xGovernment policy _zUnited States. |
|
| 650 | 2 |
_aClinical Trials as Topic _xstandards _zUnited States. |
|
| 650 | 2 |
_aDrug Evaluation _xstandards _zUnited States. |
|
| 700 | 1 |
_aGuarino, Richard A., _d1935- |
|
| 830 | 0 |
_aDrugs and the pharmaceutical sciences; _vv. 56. |
|
| 942 |
_2ddc _cBK |
||